Burlingame, July 11, 2024 (GLOBE NEWSWIRE) — CoherentMI printed a report, titled, U.S. Colorectal Most cancers Screening Market is estimated to worth at US$ 5,952.2 Million within the 12 months 2024, and is anticipated to succeed in a US$ 10,618.9 Million by 2031, with rising at a CAGR of seven.5% throughout forecast interval 2024-2031.
Market Dynamics:
The U.S. Colorectal Most cancers Screening Market is being primarily pushed by the growing prevalence of colorectal most cancers in the US. Moreover, the rising consciousness in regards to the significance of early detection and screening for colorectal most cancers among the many inhabitants can also be fueling the market development.
Market Report Scope:
| Report Protection | Particulars | |
| Examine Interval | 2024 – 2031 | |
| Base Yr of Estimation | 2023 | |
| CAGR | 7.5% | |
| Largest Market | Northeast | |
| Market Focus | Excessive | |
| Main Gamers | Polymedco Inc., Eiken Chemical Co. Ltd., Sysmex Company, Quidel Company, Novigenix SA and Amongst Others. | |
| Segments Lined | By Check Sort, By Imaging Sort, By Finish Person | |
| Report Protection | Income Forecast, Aggressive Panorama, Progress Components, and Tendencies | |
| Progress Drivers | • Growing prevalence of colorectal most cancers • Rising adoption of non-invasive screening strategies |
|
| Restraints & Challenges | • Dangers and problems related to colorectal most cancers screening | |
Key Market Takeaways:
- U.S. Colorectal Most cancers Screening Market Dimension is anticipated to witness a CAGR of seven.5% in the course of the forecast interval 2024-2031, owing to the rising incidence of colorectal most cancers and growing consciousness in regards to the significance of early screening and prognosis.
- On the premise of Check Sort, the Fecal Immunochemical Check section is predicted to carry a dominant place, owing to its accuracy and comfort.
- When it comes to Imaging Sort, the Sigmoidoscopy section is predicted to steer the market, as a result of its detailed visualization capabilities.
- The Hospital section is dominating the Finish Person class, and North America is predicted to carry a dominant place when it comes to area.
- Key gamers working within the U.S. Colorectal Most cancers Screening Market embrace Polymedco Inc., Eiken Chemical Co. Ltd., Sysmex Company, and others, who’re specializing in increasing their product choices and geographical presence to capitalize on the rising market alternatives.
Market Tendencies:
One key pattern within the U.S. Colorectal Most cancers Screening Market is the adoption of non-invasive screening exams, reminiscent of fecal immunochemical exams (FIT) and stool DNA exams, that are gaining reputation as a result of their comfort and ease of use. One other pattern is the growing deal with customized drugs and focused therapies for the therapy of colorectal most cancers, which is driving analysis and improvement actions available in the market.
Latest Improvement:
- In January 2022, QIAGEN revealed new makes use of for QIAcuity, their ultrasensitive digital PCR expertise that has raised the bar by processing samples in two hours as an alternative of 5 hours as an alternative of 5 hours like othwe techniques do by utilizing so-called nanoplates.
- In October 2020, Actual Sciences Corp declared an extension of the contract for the promotion of Cologaurd, the primary and solely non-invasive stool DNA screening take a look at for colorectal most cancers licensed by the US FDA.
Learn a whole market analysis report, “U.S. Colorectal Most cancers Screening Market, By Check Sort, By Imaging Sort, By Finish Person, and different Section Forecast 2024-2031“, Revealed by CoherentMI.
Rising Demand for Non-Invasive Screening Exams
The U.S. Colorectal Most cancers Screening Market is witnessing a rising demand for non-invasive screening exams reminiscent of Fecal Immunochemical Check (FIT) and stool DNA take a look at. These exams are most popular by sufferers as a result of their ease of use and accuracy in detecting colorectal most cancers. The Fecal Immunochemical Check (FIT) section is predicted to dominate the market within the coming years, as it’s a broadly accepted methodology for detecting colorectal most cancers. The comfort and effectiveness of those non-invasive exams are driving the market development and presenting a big alternative for producers and healthcare suppliers to cater to the growing demand for such screening choices.
Rising Adoption of Superior Imaging Applied sciences
One other market alternative within the U.S. Colorectal Most cancers Screening Market lies within the rising adoption of superior imaging applied sciences reminiscent of Sigmoidoscopy and Digital Colonoscopy. These imaging strategies provide detailed visualization of the colon and rectum, aiding within the early detection and prognosis of colorectal most cancers. The Sigmoidoscopy section is predicted to dominate the market, as it’s a minimally invasive process with excessive accuracy in detecting colorectal abnormalities. The growing consciousness in regards to the significance of early screening and prognosis of colorectal most cancers is driving the adoption of those superior imaging applied sciences, presenting a profitable alternative for market gamers to develop their choices on this section.
General, the U.S. Colorectal Most cancers Screening Market presents profitable alternatives for market gamers to introduce progressive and superior screening strategies, cater to the rising demand for non-invasive exams, and develop their presence in key areas. With the growing deal with early detection and prognosis of colorectal most cancers, market gamers are investing in analysis and improvement actions to reinforce their product choices and enhance the screening outcomes for sufferers. The important thing takeaway for stakeholders available in the market is to align their methods with the evolving tendencies and technological developments to capitalize on the rising demand for colorectal most cancers screening options within the U.S.
U.S. Colorectal Most cancers Screening Market Segmentation:
- By Check Sort
- Fecal Immunochemical Check (FIT)
- Guaiac-based Fecal Occult Blood Check
- Stool DNA Check
- Others
- By Imaging Sort
- Sigmoidoscopy
- Colonoscopy
- Digital Colonoscopy
- Others
- By Finish Person
- Hospitals
- Diagnostic Laboratories
- Educational and Analysis Institutes
- Others
- By Area
- Northeast
- West
- South
- Midwest
Buy Newest Version of this Analysis Report @ https://www.coherentmi.com/industry-reports/us-colorectal-cancer-screening-market/buynow
High Questions Answered on this Report:
- What elements are impeding the expansion of the U.S. Colorectal Most cancers Screening Market?
- What are the first drivers fueling the expansion of the U.S. Colorectal Most cancers Screening Market?
- Which section dominates because the main part within the U.S. Colorectal Most cancers Screening Market?
- Who’re the important thing gamers actively collaborating within the U.S. Colorectal Most cancers Screening Market?
- Which area is predicted to take the lead within the U.S. Colorectal Most cancers Screening Market?
- What’s the projected CAGR of the U.S. Colorectal Most cancers Screening Market?
Discover Extra Trending Reviews Under:
International Sodium Channel Blockers Market is Segmented By Product (Antiarrhythmic Brokers, Native Anesthetics, Anticonvulsants, Analgesics, and Others), By Therapeutic Space (Cardiology, Neurology, Anesthesiology, Ache Administration, and Others), By Route of Administration (Oral, Parenteral, and Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and On-line Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Center East & Africa). The report presents the worth (in USD Billion) for the above-mentioned segments.
International Fast Influenza Diagnostic Exams Market is Segmented By Check Sort (Fast Molecular Assays, Fast Immunoassay, and Others), By Influenza Sort (Influenza Sort A, Influenza Sort B, Influenza Sort C, and Others), By Specimen Sort (Nasopharyngeal Swab, Nasal Swab, Throat Swab, and Others), By Finish Person (Diagnostic Laboratories, Diagnostic Laboratories, Diagnostic Laboratories, and Others), By Area (North America, Europe, Asia Pacific, Latin America, Center East and Africa) . The report presents the worth (in USD billion) for the above-mentioned segments.
Australia Blood Ketone Meter Market is Segmented By Product Sort (Solely Blood Ketone Monitoring, Blood Glucose and Ketone Monitoring, Consumables), By Utility (Human, Veterinary), By Finish Person (Hospitals, Diagnostic Facilities, Ambulatory Surgical Facilities, Dwelling Care Settings, Veterinary Hospitals and Clinics, Others). The report presents the worth (in USD million) for the above talked about segments.
About Us:
At CoherentMI, we’re a number one international market intelligence firm devoted to offering complete insights, evaluation, and strategic options to empower companies and organizations worldwide. Furthermore, CoherentMI is a subsidiary of Coherent Market Insights Pvt Ltd., which is a market intelligence and consulting group that helps companies in important enterprise selections. With our cutting-edge expertise and skilled crew of {industry} consultants, we ship actionable intelligence that helps our purchasers make knowledgeable selections and keep forward in right this moment’s quickly altering enterprise panorama.
